Swiss National Bank
KALA icon

Swiss National Bank’s KALA BIO KALA Stock Holding History

Swiss National Bank’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-35
Closed -$231K – 2739
2021
Q3 		$231K Hold
35
– – ﹤0.01% 2617
2021
Q2 		$467K Buy
35
+5
+17% +$78.6K ﹤0.01% 2627
2021
Q1 		$511K Hold
30
– – ﹤0.01% 2456
2020
Q4 		$514K Hold
30
– – ﹤0.01% 2457
2020
Q3 		$569K Buy
30
+1
+3% +$23K ﹤0.01% 2333
2020
Q2 		$768K Buy
+29
New +$821K ﹤0.01% 2247

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Swiss National Bank's KALA Position: Q4 2021 in Review

Swiss National Bank sold out of KALA BIO (KALA) in Q4 2021, closing a stake of 35 shares — an estimated $231K sold.

Swiss National Bank first reported a position in KALA in Q2 2020 and held it in 6 quarters. The position peaked at $768K in Q2 2020. 79 funds tracked by Wall St. Rank hold KALA as of Q4 2021.

  • Swiss National Bank reported no remaining KALA BIO position as of Q4 2021 after selling out during the quarter.
  • Swiss National Bank sold 35 KALA BIO shares in Q4 2021, an estimated $231K.
  • Swiss National Bank first reported a position in KALA BIO in Q2 2020 and held it in 6 quarters.
  • Swiss National Bank's KALA BIO position peaked at $768K in Q2 2020.
  • 79 funds tracked by Wall St. Rank held KALA BIO as of Q4 2021.

Based on Swiss National Bank's 13F filing for Q4 2021, filed 8 Feb 2022.